GLP-2 TRZ is a research peptide used in preclinical laboratory models involving metabolic, mitochondrial, immune, or regenerative pathways.

What is GLP-2 TRZ?

GLP-2 TRZ, often informally referred to in research settings as GLP-2, is a synthetic peptide supplied exclusively for laboratory research use. It is classified as a dual-receptor agonist studied for its interaction with both the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor.

This dual-receptor profile distinguishes GLP-2 TRZ from earlier single-pathway GLP-1 research compounds and allows investigation across multiple hormonal signaling pathways associated with metabolic and endocrine regulation.

In preclinical research models, GLP-2 TRZ has been examined for its engagement with incretin-related signaling pathways. GLP-1 and GIP are endogenously produced peptides released in response to nutrient exposure and are commonly studied for their roles in insulin signaling, glucagon modulation, gastric motility signaling, and appetite-related regulatory mechanisms.

GLP-2 TRZ is supplied as a high-purity, lyophilized research peptide intended for handling and reconstitution under controlled laboratory conditions only.

Mechanism of Interest

• Angiogenesis: Observed to influence vascular endothelial pathways.
• Tissue Repair: Supports modeling of gastric, tendon, and muscular healing.
• Cytoprotection: Evaluated for protective effects in oxidative environments.

Key Research Applications

- Tissue repair and regeneration research

- Inflammation pathway modeling

- Angiogenesis studies

Handling & Storage

Lyophilized: Store at –20°C, protect from light and moisture.

Reconstituted: Store at 2–8°C, avoid freeze–thaw cycles.

Research Use Only

This product is supplied strictly for laboratory, research, and development use. Not for human consumption or therapeutic application.